Annovis Bio, Inc. · NYSE:ANVS
Hoffman Michael B bought 76,344 Annovis Bio, Inc. shares (Form 4)
Traded May 20, 2026 · Filed May 21, 2026
On May 20, 2026, Hoffman Michael B (Director) bought 76,344 Annovis Bio, Inc. shares at an average US$1.87 for US$143K, leaving 3,364,883 shares. Filed May 21, 2026 (Form 4).
- Bought
- 76,344 shares
- Price
- US$1.87 average (US$1.75 to US$1.90)
- Value
- US$143K
- Holding after
- 3,364,883 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 20, 2026 | Common Stock | Buy | 2,562 | US$1.75 | 3,291,101 | Direct |
| May 20, 2026 | Common Stock | Buy | 18,849 | US$1.80 | 3,309,950 | Direct |
| May 20, 2026 | Common Stock | Buy | 54,933 | US$1.90 | 3,364,883 | Direct |
Source
Related
- Annovis Bio, Inc.
- Hoffman Michael B
- Annovis Bio, Inc. shareholders
- Form 4 · Hoffman Michael B · Apr 3, 2026
- Schedule 13G/A · Empery Asset Management, LP · Oct 15, 2026
- Schedule 13G · Highbridge Capital Management LLC · Aug 14, 2026
- Schedule 13G · Empery Asset Management, LP · Jul 29, 2026
- Schedule 13G/A · CVI Investments, Inc. · May 12, 2025
- Schedule 13G · CVI Investments, Inc. · Feb 10, 2025